A judge dismissed indictments against two of the president’s foes, but a new Pentagon investigation of a prominent Democrat shows how he is using a whole-of-government approach to punish those who ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

In 2025, success in the markets depends on how intelligently you use technology. From retail traders to institutional investors, everyone is turning to bot trading — a system where trades are executed ...

Children as young as 4 years old are capable of finding efficient solutions to complex problems, such as independently inventing sorting algorithms developed by computer scientists. The scientists ...

On Thursday, the U.S. Food and Drug Administration (FDA) extended the Prescription Drug User Fee Act (PDUFA) goal date for Agios Pharmaceuticals, Inc.’s (NASDAQ:AGIO) supplemental New Drug Application ...

FEED will allow Soldiers to use their meal entitlements outside of traditional Army-operated dining facilities for the first time. During the pilot, 200 Soldiers from the 61st Quartermaster Battalion ...

The Atlanta-based carrier said it "always" complies with regulations. Airfare prices are traditionally dynamic due to an array of variable external factors from seasonal demand and jet fuel prices to ...

July 14 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the use of its respiratory syncytial ...

Every piece of land carries a story of development, transformation, and human impact. From expanding urban centers to shifting agricultural zones, land use plays a crucial role in shaping both local ...

Immigration and Customs Enforcement (ICE) is using a smartphone app to identify people based on an image of their fingerprints or face, 404 Media reported Thursday, based on a review of internal ICE ...

GSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to expand the use of its adjuvanted recombinant respiratory syncytial virus (RSV ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from respiratory ...